Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOTAGLIFLOZIN for Chronic left ventricular failure: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 31 adverse event reports in the FDA FAERS database where SOTAGLIFLOZIN was used for Chronic left ventricular failure.

Most Reported Side Effects for SOTAGLIFLOZIN

Side Effect Reports % Deaths Hosp.
Dizziness 51 10.8% 0 3
Diarrhoea 45 9.5% 0 1
Therapy interrupted 28 5.9% 0 6
Death 24 5.1% 24 0
Off label use 24 5.1% 0 1
Dyspnoea 22 4.7% 0 2
Headache 21 4.5% 0 0
Urinary tract infection 21 4.5% 0 6
Product use issue 20 4.2% 0 5
Nausea 18 3.8% 0 0
Fungal infection 16 3.4% 0 2
Fatigue 14 3.0% 0 1
Vomiting 14 3.0% 0 0
Drug ineffective 13 2.8% 0 1
Hospitalisation 12 2.5% 0 12

Other Indications for SOTAGLIFLOZIN

Product used for unknown indication (292) Cardiac failure (31) Cardiac failure congestive (29) Type 2 diabetes mellitus (17) Cardiac disorder (11) Left ventricular failure (8) Cardiomyopathy (5)

Other Drugs Used for Chronic left ventricular failure

SACUBITRIL\VALSARTAN (276) TAFAMIDIS (31) SPIRONOLACTONE (15) TORSEMIDE (9) IVABRADINE (7) BISOPROLOL (6) BUMETANIDE (6) FUROSEMIDE (6) CANDESARTAN CILEXETIL (5) CARVEDILOL (5)

Related Pages

SOTAGLIFLOZIN Full Profile All Chronic left ventricular failure Drugs SOTAGLIFLOZIN Demographics SOTAGLIFLOZIN Timeline